Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure. (Q51559826)

7 April 2018

title

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure. (English)

1 reference

7 April 2018

0 references

1 reference

Bastyr EJ 3rd

1

1 reference

7 April 2018

Johnson ME

2

1 reference

7 April 2018

Trautmann ME

3

1 reference

7 April 2018

Anderson JH Jr

4

1 reference

7 April 2018

Vignati L

5

1 reference

7 April 2018

publication date

1 October 1999

1 reference

7 April 2018

published in

Clinical Therapeutics

1 reference

7 April 2018

volume

21

1 reference

7 April 2018

issue

10

1 reference

7 April 2018

page(s)

1703-1714

1 reference

7 April 2018

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Effect of the insulin analogue [LYS(B28),PRO(B29)] on blood glucose control

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Implementation of treatment protocols in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980049-6

7 January 2021

10.1016/S0149-2918(99)80049-6

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018